RLAY
Relay Therapeutics
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
RLAY fundamentals
Relay Therapeutics (RLAY) expects to report earnings on Aug 5, 2025, with estimated revenue of 66.67K (YoY 0.00%), and EPS at -0.47 (YoY +31.88%).
Revenue estimate / YoY
66.67K
0.00%
EPS estimate / YoY
-0.47
+31.88%
Report date
Aug 5, 2025
EPS
Revenue
Revenue & Expenses
RLAY has released its 2025 Q1 earnings report, with revenue of 7.68M, reflecting a YoY change of -23.26%, and net profit of -77.06M, showing a YoY change of 5.31%. The Sankey diagram below clearly presents RLAY's revenue sources and cost distribution.
Key Indicators
Relay Therapeutics (RLAY) key financial stats and ratios, covering profitability, financial health, and leverage.
Relay Therapeutics (RLAY)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Relay Therapeutics (RLAY)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Relay Therapeutics (RLAY)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Relay Therapeutics (RLAY) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Relay Therapeutics (RLAY) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What were the key takeaways from Relay Therapeutics’s earnings call?What guidance did Relay Therapeutics’s management provide for the next earnings period? What factors drove the changes in Relay Therapeutics’s revenue and profit?How were Relay Therapeutics’s latest financial results overall?What is Relay Therapeutics’s latest dividend and current dividend yield?Did Relay Therapeutics beat or miss consensus estimates last quarter?What is the market’s earnings forecast for Relay Therapeutics next quarter?What is the revenue and EPS growth rate for Relay Therapeutics year over year?